TerSera acquires global rights to MacroGenics’ MARGENZA for breast cancer treatment

MacroGenics is into the discovery, development, manufacturing, and commercialization of monoclonal antibody-based therapies for cancer treatment. Credit: AVAKA photo from Pixabay.